NRAS-mutant advanced melanoma

Clinical trials for NRAS-mutant advanced melanoma explained in plain language.

Never miss a new study

Get alerted when new NRAS-mutant advanced melanoma trials appear

Sign up with your email to follow new studies for NRAS-mutant advanced melanoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet finished but already full! 1

New hope for hard-to-treat melanoma: drug combo targets NRAS mutation

Disease control Ongoing

This early-stage study tests a new drug called belvarafenib, alone or with other drugs (cobimetinib and nivolumab), in people with advanced melanoma that has a specific NRAS gene change and has stopped responding to standard immunotherapy. The main goals are to check safety and f…

Matched conditions: NRAS-MUTANT ADVANCED MELANOMA

Phase 1 • Sponsor: Genentech, Inc. • Aim: Disease control

Last updated Jul 03, 2026 00:00 UTC

NRAS-mutant advanced melanoma

Get alerted when new NRAS-mutant advanced melanoma trials appear

New hope for hard-to-treat melanoma: drug combo targets NRAS mutation